Revision history of "DEVELOPMENT OF UNIVERSAL T CELLULAS FOR USE IN LEUKEMIA IMMUNOTHERAPY PROTOCOLS" (Q3167751)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 21:2621:26, 10 October 2024DG Regio talk contribs 81,534 bytes +10 Changed label, description and/or aliases in pt
  • curprev 21:2621:26, 10 October 2024DG Regio talk contribs 81,524 bytes +37 Set a claim value: summary (P836): O transplante de células T que expressa receptores de antigénio quiméricos (CARs) é um tratamento potente que tem mostrado resultados muito encorajadores em leucemias refratárias, linfomas e mielomas. O sucesso da aplicação clínica dos CAR-Ts e sua reprodutibilidade dependem em grande parte da qualidade das células T utilizadas e do método utilizado para a transferência de genes. Neste tipo de terapias, a expressão de CARs é geralmente realizada por...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 02:1602:16, 18 August 2022DG Regio talk contribs 80,215 bytes +55,469 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 17:3717:37, 12 October 2021DG Regio talk contribs 13,078 bytes +2,585 Created claim: summary (P836): T-cell transplantation expressing chimeric antigen receptors (CARs) is a potent treatment that has shown very encouraging results in refractory leukemias, lymphomas and myelomas. The success of the clinical application of CAR-Ts and their reproducibility depend largely on the quality of the T-cells used and the method used for gene transfer. In this type of therapies, the expression of CARs is usually carried out by transduction of autologous T-...
  • curprev 17:3717:37, 12 October 2021DG Regio talk contribs 10,493 bytes −2,585 Removed claim: summary (P836): T-cell transplantation expressing chimeric antigen receptors (CARs) is a potent treatment that has shown very encouraging results in refractory leukemias, lymphomas and myelomas. The success of the clinical application of CAR-Ts and their reproducibility depend largely on the quality of the T-cells used and the method used for gene transfer. In this type of therapies, the expression of CARs is usually carried out by transduction of autologous...
  • curprev 16:2216:22, 12 October 2021DG Regio talk contribs 13,078 bytes +138 Changed label, description and/or aliases in en: translated_label
  • curprev 16:2216:22, 12 October 2021DG Regio talk contribs 12,940 bytes +2,585 Created claim: summary (P836): T-cell transplantation expressing chimeric antigen receptors (CARs) is a potent treatment that has shown very encouraging results in refractory leukemias, lymphomas and myelomas. The success of the clinical application of CAR-Ts and their reproducibility depend largely on the quality of the T-cells used and the method used for gene transfer. In this type of therapies, the expression of CARs is usually carried out by transduction of autologous T-...

10 October 2021

9 October 2021

8 October 2021